Search Results

There are 24953 results for: content related to: Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. You have free access to this content
    Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

    Hepatology

    Volume 33, Issue 6, June 2001, Pages: 1358–1364, Luigi E. Adinolfi, Michele Gambardella, Augusto Andreana, Marie-françoise Tripodi, Riccardo Utili and Giuseppe Ruggiero

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.24432

  3. You have free access to this content
    Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 1828–1837, Anna S. Lok, James E. Everhart, Raymond T. Chung, Hae-Young Kim, Gregory T. Everson, John C. Hoefs, Joel K. Greenson, Richard K. Sterling, Karen L. Lindsay, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Marc G. Ghany, Chihiro Morishima and HALT-C Trial Group

    Version of Record online : 2 FEB 2009, DOI: 10.1002/hep.22865

  4. You have free access to this content
    Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

    Hepatology

    Volume 36, Issue 5, November 2002, Pages: 1266–1272, Dinesh Kumar, Geoffrey C. Farrell, Caroline Fung and Jacob George

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2002.36370

  5. Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks

    Liver International

    Volume 29, Issue 2, February 2009, Pages: 237–241, Maribel Rodriguez-Torres, Sugantha Govindarajan, Moises Diago, Thomas Morgan, Bhupinderjit Anand, Karl Barange, Frank Suter, Amy Lin, Gregory Hooper and Mitchell Shiffman

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1478-3231.2008.01859.x

  6. You have free access to this content
    Abstracts 1097 to 1314

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 725A–821A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22021

  7. Microsomal triglyceride transfer protein polymorphism (−493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C

    Liver International

    Volume 29, Issue 4, April 2009, Pages: 557–565, Silvia Mirandola, Christoph H. Österreicher, Moira Marcolongo, Christian Datz, Elmar Aigner, Anne Schlabrakowski, Stefano Realdon, Martina Gerotto, Alfredo Alberti and Felix Stickel

    Version of Record online : 15 OCT 2008, DOI: 10.1111/j.1478-3231.2008.01892.x

  8. You have free access to this content
    Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 10, November 2014, Pages: 1209–1222, L. Fedchuk, F. Nascimbeni, R. Pais, F. Charlotte, C. Housset, V. Ratziu and forthe LIDO Study Group

    Version of Record online : 29 SEP 2014, DOI: 10.1111/apt.12963

  9. You have free access to this content
    Abstracts 1072 to 1346

    Hepatology

    Volume 44, Issue S1, October 2006, Pages: 588A–691A,

    Version of Record online : 25 SEP 2006, DOI: 10.1002/hep.21399

  10. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  11. You have free access to this content
    Steatohepatitis Clinical Themes

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 472A–524A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26849

  12. Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis

    Journal of Medical Virology

    Volume 75, Issue 4, April 2005, Pages: 550–558, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi and Hiromitsu Kumada

    Version of Record online : 15 FEB 2005, DOI: 10.1002/jmv.20298

  13. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22645

  14. You have free access to this content
    Steatohepatitis Mechanisms

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 524A–563A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26850

  15. You have free access to this content
    Hepatic steatosis and hepatitis C: Still unhappy bedfellows?

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 96–101, Shinn-Jang Hwang and Shou-Dong Lee

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06542.x

  16. You have free access to this content
    Body mass index as a predictor of hepatic steatosis in living liver donors

    Liver Transplantation

    Volume 7, Issue 5, May 2001, Pages: 409–414, Mary E. Rinella, Estella Alonso, Sambasiva Rao, Peter Whitington, Jonathan Fryer, Michael Abecassis, Riccardo Superina, Steven L. Flamm and Andres T. Blei

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jlts.2001.23787

  17. Liver fat content investigated by magnetic resonance spectroscopy in obese children and youths included in multidisciplinary treatment

    Clinical Obesity

    Volume 2, Issue 1-2, February/April 2012, Pages: 41–49, D. S. Bille, E. Chabanova, M. Gamborg, C. E. Fonvig, T. R. H. Nielsen, E. Thisted, H. S. Thomsen and J-C. Holm

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1758-8111.2012.00038.x

  18. You have free access to this content
    AASLD Abstract (pp. 162A–266A)

    Hepatology

    Volume 40, Issue S4, October 2004, Pages: 370A–473A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840400505

  19. The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 5, March 2015, Pages: 467–476, K. Lau, S. E. Baumeister, W. Lieb, P. J. Meffert, M. M. Lerch, J. Mayerle and H. Völzke

    Version of Record online : 15 JAN 2015, DOI: 10.1111/apt.13067

  20. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection (Br J Surg 2010: 97: 1331–1339)

    British Journal of Surgery

    Volume 97, Issue 9, September 2010, Page: 1339, M. J. Walsh

    Version of Record online : 28 JUL 2010, DOI: 10.1002/bjs.7195